Capital Fund Management (CFM)
BSX icon

Capital Fund Management (CFM)’s Boston Scientific BSX Stock Holding History

Capital Fund Management (CFM)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
29,000
-382,900
-93% -$30.6M 0.01% 1406
2025
Q4 		$39.3M Buy
411,900
+321,300
+355% +$31.5M 0.11% 251
2025
Q3 		$8.85M Sell
90,600
-12,300
-12% -$1.27M 0.02% 899
2025
Q2 		$11.1M Sell
102,900
-6,800
-6% -$688K 0.03% 700
2025
Q1 		$11.1M Sell
109,700
-105,000
-49% -$10.6M 0.03% 635
2024
Q4 		$19.2M Sell
214,700
-64,900
-23% -$5.71M 0.05% 492
2024
Q3 		$23.4M Buy
279,600
+160,000
+134% +$12.6M 0.06% 401
2024
Q2 		$9.21M Buy
119,600
+108,800
+1,007% +$7.96M 0.03% 706
2024
Q1 		$740K Buy
+10,800
New +$694K ﹤0.01% 1794
2023
Q4 		– Sell
-24,100
Closed -$1.27M – 2111
2023
Q3 		$1.27M Sell
24,100
-6,200
-20% -$325K ﹤0.01% 1555
2023
Q2 		$1.64M Sell
30,300
-15,400
-34% -$804K 0.01% 1259
2023
Q1 		$2.29M Buy
+45,700
New +$2.15M 0.01% 1021
2020
Q4 		– Sell
-10,200
Closed -$390K – 1295
2020
Q3 		$390K Buy
+10,200
New +$393K ﹤0.01% 1081
2020
Q2 		– Sell
-11,400
Closed -$372K – 1077
2020
Q1 		$372K Buy
+11,400
New +$445K 0.01% 1149
2019
Q3 		– Sell
-7,700
Closed -$331K – 1676
2019
Q2 		$331K Buy
+7,700
New +$296K ﹤0.01% 1344
2019
Q1 		– Sell
-10,700
Closed -$378K – 1681
2018
Q4 		$378K Sell
10,700
-2,500
-19% -$90.7K ﹤0.01% 1511
2018
Q3 		$508K Buy
+13,200
New +$461K ﹤0.01% 1588
2015
Q3 		– Sell
-19,900
Closed -$352K – 1423
2015
Q2 		$352K Buy
19,900
+300
+2% +$5.36K ﹤0.01% 1200
2015
Q1 		$348K Buy
+19,600
New +$310K ﹤0.01% 1170

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Fund Management (CFM)'s BSX Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Boston Scientific (BSX) stake by 45% in Q1 2026, buying an estimated $41.1M and bringing the position to 1,665,947 shares worth $105M. The position accounts for 0.47% of the portfolio, ranked #17.

Capital Fund Management (CFM) first reported a position in BSX in Q2 2013 and has held it in 20 quarters since. The position peaked at $110M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Capital Fund Management (CFM) held 1,665,947 shares of Boston Scientific worth $105M as of Q1 2026.
  • Capital Fund Management (CFM) bought 513,899 Boston Scientific shares in Q1 2026, an estimated $41.1M.
  • Boston Scientific made up 0.47% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #17 holding.
  • Capital Fund Management (CFM) first reported a position in Boston Scientific in Q2 2013 and has held it in 20 quarters since.
  • Capital Fund Management (CFM)'s Boston Scientific position peaked at $110M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.